Genenta Science S.p.A. (GNTA:NASDAQ) closed at $0.637 on October 27, 2026, up 6.68% on the day. The stock trades 81.2% below its 52-week high of $3.39 and 15.8% above its 52-week low of $0.550. Over the past year, it lost 81.2%. Genenta Science S.p.A. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, GNTA closed higher on 99 days (39%). Its best day was October 24, 2025 (+91.95%) and its worst was October 27, 2025 (-46.45%). The stock moved 10% or more in a single session 37 times. It opened at least 5% above the previous day's high 10 times.
Genenta Science SPA is a clinical-stage biotechnology company pioneering the development of lentivirus-based first-in-class gene and cell therapies in cancer.
Find more stocks like GNTA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.